Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NMS-03305293 |
Synonyms | |
Therapy Description |
NMS-03305293 inhibits PARP, potentially resulting in decreased repair of DNA damage and increased tumor cell apoptosis (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NMS-03305293 | NMS03305293|NMS 03305293 | PARP Inhibitor (Pan) 31 | NMS-03305293 inhibits PARP, potentially resulting in decreased repair of DNA damage and increased tumor cell apoptosis (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04182516 | Phase I | NMS-03305293 | Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors | Terminated | USA | ITA | GBR | BGR | 1 |